Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Neuroblastoma 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Biphenotypic, Acute 1Heart Failure 1Ganglioneuroblastoma 1Dendritic Cell Sarcoma, Interdigitating 1Cardiotoxicity 1Blast Crisis 1

Interventions

Cytarabine 3ponatinib 2blinatumomab 2Idarubicin 2Cladribine 2venetoclax 1nilotinib 1midostaurin 1merphos 1gilteritinib 1fludarabine 1bosutinib 1asciminib 1Succimer 1Specimen Handling 1Razoxane 1Positron-Emission Tomography 1Pentetic Acid 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Methotrexate 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1Geritol 1Gemtuzumab 1Edetic Acid 1Dexrazoxane 1Dasatinib 1Cyclophosphamide 1Blood Component Removal 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Blast Crisis × Dexrazoxane × Clear all
NCT03589729 2026-05-22

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

M.D. Anderson Cancer Center

Phase 2 Recruiting
100 enrolled
MyeloidOther hematologic neoplasmSarcoma

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡